1. Li N, Lin JL, Ma XZ*, Chen XY. Clinical characteristics of Elizabethkingia meningoseptica nosocomial infections and literature review. Chinese Journal of Clinical Pharmacology. 2020;36(10):215-218.
2. Xue F, Ma XZ*, Zheng B. Lefamulin: Clinical pharmacological research of a novel pleuromutilin antibiotic for human use. Chinese Journal of Antibiotics. 2021 (Online First).
3. Duan Y, Ma XZ*, Lin JL, Zhu TY, Chen XY. Clinical characteristics and drug resistance analysis of Klebsiella pneumoniae bloodstream infections. Chinese Journal of Clinical Pharmacology. 2019;35(15):1584-1591.
4. Ma XZ, Zheng B*, Chen XY, Wang YQ, Feng LL. Pathogen distribution and drug susceptibility in bloodstream infections of neutropenic patients. Chinese Journal of Clinical Pharmacology. 2019;35(7):40-43.
5. Ma XZ, Zheng B*, Wang YQ, Feng LL, Chen XY. Etiological distribution and drug resistance in urosepsis. Chinese Journal of Clinical Pharmacology. 2019;35(1):38-41.
6. Ma XZ, Zheng B*, Li XY, Chen XY, Cui H. Clinical features and etiological analysis of adult bloodstream infections. Chinese Journal of Nosocomiology. 2017;27(17):3860-3863.
7. Ma XZ, Li XY*, Zheng B. Clinical and microbiological characteristics of 144 infective endocarditis cases. Chinese Journal of Infection and Chemotherapy. 2017;17(5):498-503.
8. Zhu SN, Ma XZ*, Chu Y, Li DT, Xu CY. Population pharmacokinetics of cefazolin sodium pentahydrate. Chinese Journal of Clinical Pharmacology. 2017;33(2):120-122.
9. Ma XZ, Li XY, Xue F, Zhang J, Lv Y. Imipenem-induced expression changes of adeB in drug-resistant Acinetobacter baumannii. Chinese Journal of Clinical Pharmacology. 2014;30(8):696-700.
10. Ma XZ, Li XY, Que CL, Lv Y. Underlying heart disease and microbiological spectrum of adult infective endocarditis in one Chinese university hospital: A 10-year retrospective study. Internal Medicine Journal. 2013;43(12):1303-1309.